Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids in Osteoarthritis of the Knee
NCT04992624Phase 2Recruiting
- Start
- Feb 2022
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, dronabinol in osteoarthritis (OA). Started Feb 2022; status: recruiting.
02
Drugs
cannabidioldronabinol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04992624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992624.